Drugs & Targets Hoffmann-LaRoche’s Alecensaro receives Health Canada approval NSCLC November 04, 2016Vol.42 No.41
Drugs & Targets BMS receives Health Canada conditional approval for Opdivo-Yervoy combination November 04, 2016Vol.42 No.41
In Brief Merck and ACS publish report on Global burden of cancer in women November 04, 2016Vol.42 No.41
Drugs & Targets Xtandi Receives FDA Approval for Supplemental New Drug Application October 28, 2016Vol.42 No.40
In Brief Varian Medical Systems and McKesson Specialty Health announce a strategic agreement October 28, 2016Vol.42 No.40
